News brief
On September 2, 2026, per PR Newswire, oncology patient navigation and value-based care company Thyme Care closed over $125M in a Series E led by Morgan Health with Humana, CVS Health Ventures and a16z Bio + Health at a valuation above $2B. The company was co-founded by Robin Shah and oncologist Bobby Green.
Connected profiles
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- www.prnewswire.com ↗Published Sep 2, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年9月2日，据PR Newswire报道，肿瘤患者导航与价值医疗支付公司Thyme Care完成超过1.25亿美元E轮融资，由Morgan Health领投，Humana、CVS Health Ventures和a16z Bio + Health等参与，估值超过20亿美元。公司由Robin Shah与肿瘤医生Bobby Green共同创立。